Jim ButschliPharmaceuticalsPackagers: Do you understand your suppliers’ processes?LIVE FROM PDA 2013: Parenteral Drug Assn. speaker urges companies to better understand each other’s businesses to improve sterile product packaging.April 15, 2013Package DesignRollprint to install pouch manufacturing linePackaging material supplier investing $1.25 million in Swiss machine for sterile medical packaging and other demanding applications.April 10, 2013MaterialsPharmapack Europe winners reflect package diversityPharmaceutical package winners include Novo Nordisk insulin pen, Weleda’s carton for vials, and a blister-pack carrying case.April 8, 2013Packaging/FillingVetter’s new commercial filling line validated and ready for cGMP fillingFor prefilled syringes, line offers track-and-trace capability; first customer project underway.April 8, 2013PharmaceuticalsISPE releases new guidance on booklet labelsOrganization says it’s the industry’s first-ever guidance to help companies conducting clinical trials globally standardize their use of booklet labels.April 4, 2013MaterialsCombination products: The future of medicineThe advancement of exciting medical treatments depends in large part on education and communication.April 3, 2013RegulatoryVoices of Leadership: A Q&A with Desmond Hunt, U.S. Pharmacopeial ConventionThe scientific organization is involved in multiple packaging and labeling projects related to pharmaceuticals, biologics, and combination products.April 1, 2013Pharmaceuticals'Reverse settlements' case heard in the U.S. Supreme CourtFTC argues 'pay-to-delay' agreements by brand-name pharmaceutical firms to generic producers violate antitrust laws; decision expected by June.March 28, 2013PharmaceuticalsFolding carton for Weleda earns Pharmapack honorsSupplier Edelmann recognized for two-part folding carton that can be easily handled and automatically filled.March 25, 2013PharmaceuticalsVoices of Leadership: A Q&A with Nancy Limback, Sanofi US, Chattem Consumer Healthcare Div.Exploring Rx-to-OTC switches, their packaging considerations, anti-counterfeiting, developing global markets, and patient adherence.March 25, 2013Previous PagePage 128 of 135Next Page
